“…En In children aged between 6 and 11 years with uncontrolled persistent asthma with low doses of ICS, doubling the ICS dose has a similar effect on clinical control and lung function than adding a LABA. 576 However, the clinical phenotype and the heterogeneity of the individual response to ICS, LTRA and LABA should be assessed, 539 , 577 therefore, it is necessary to closely monitor the response to treatment in children with uncontrolled asthma using ICS.…”